Literature DB >> 19494242

Competing risk regression models for epidemiologic data.

Bryan Lau1, Stephen R Cole, Stephen J Gange.   

Abstract

Competing events can preclude the event of interest from occurring in epidemiologic data and can be analyzed by using extensions of survival analysis methods. In this paper, the authors outline 3 regression approaches for estimating 2 key quantities in competing risks analysis: the cause-specific relative hazard ((cs)RH) and the subdistribution relative hazard ((sd)RH). They compare and contrast the structure of the risk sets and the interpretation of parameters obtained with these methods. They also demonstrate the use of these methods with data from the Women's Interagency HIV Study established in 1993, treating time to initiation of highly active antiretroviral therapy or to clinical disease progression as competing events. In our example, women with an injection drug use history were less likely than those without a history of injection drug use to initiate therapy prior to progression to acquired immunodeficiency syndrome or death by both measures of association ((cs)RH = 0.67, 95% confidence interval: 0.57, 0.80 and (sd)RH = 0.60, 95% confidence interval: 0.50, 0.71). Moreover, the relative hazards for disease progression prior to treatment were elevated ((cs)RH = 1.71, 95% confidence interval: 1.37, 2.13 and (sd)RH = 2.01, 95% confidence interval: 1.62, 2.51). Methods for competing risks should be used by epidemiologists, with the choice of method guided by the scientific question.

Entities:  

Mesh:

Year:  2009        PMID: 19494242      PMCID: PMC2732996          DOI: 10.1093/aje/kwp107

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  33 in total

1.  Competing risks as a multi-state model.

Authors:  Per Kragh Andersen; Steen Z Abildstrom; Susanne Rosthøj
Journal:  Stat Methods Med Res       Date:  2002-04       Impact factor: 3.021

2.  Applications of crude incidence curves.

Authors:  E L Korn; F J Dorey
Journal:  Stat Med       Date:  1992-04       Impact factor: 2.373

3.  The analysis of failure times in the presence of competing risks.

Authors:  R L Prentice; J D Kalbfleisch; A V Peterson; N Flournoy; V T Farewell; N E Breslow
Journal:  Biometrics       Date:  1978-12       Impact factor: 2.571

4.  Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection.

Authors:  G M Lucas; L W Cheever; R E Chaisson; R D Moore
Journal:  J Acquir Immune Defic Syndr       Date:  2001-07-01       Impact factor: 3.731

5.  Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data?

Authors:  M S Pepe; M Mori
Journal:  Stat Med       Date:  1993-04-30       Impact factor: 2.373

6.  Applying Cox regression to competing risks.

Authors:  M Lunn; D McNeil
Journal:  Biometrics       Date:  1995-06       Impact factor: 2.571

7.  All cause mortality in the Swiss HIV Cohort Study from 1990 to 2001 in comparison with the Swiss population.

Authors:  Olivia Keiser; Patrick Taffé; Marcel Zwahlen; Manuel Battegay; Enos Bernasconi; Rainer Weber; Martin Rickenbach
Journal:  AIDS       Date:  2004-09-03       Impact factor: 4.177

8.  Evaluating competing adverse and beneficial outcomes using a mixture model.

Authors:  Bryan Lau; Stephen R Cole; Richard D Moore; Stephen J Gange
Journal:  Stat Med       Date:  2008-09-20       Impact factor: 2.373

9.  Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risks.

Authors:  Abdel Babiker; Janet Darbyshire; Patrizio Pezzotti; Kholoud Porter; Giovanni Rezza; Sarah A Walker; Valerie Beral; Roel Coutinho; Julia Del Amo; Noël Gill; Christine Lee; Laurence Meyer; Freya Tyrer; Francois Dabis; Rodolphe Thiebaut; Sylvie Lawson-Aye; Faroudy Boufassa; Osamah Hamouda; Klaus Fischer; Patrizio Pezzotti; Giovanni Rezza; Giota Touloumi; Angelos Hatzakis; Anastasia Karafoulidou; Olga Katsarou; Ray Brettle; Jorge del Romero; Maria Prins; Birgit van Benthem; Ole Kirk; Court Pederson; Idelfonso Hernández Aguado; Santiago Pérez-Hoyos; Anne Eskild; Johan N Bruun; Mette Sannes; Caroline Sabin; Christine Lee; Anne M Johnson; Andrew N Phillips; Patrick Francioli; Philippe Vanhems; Mathias Egger; Martin Rickenbach; David Cooper; John Kaldor; Lesley Ashton; Jeanette Vizzard; Roberto Muga; Nicholas E Day; Daniela De Angelis
Journal:  Int J Epidemiol       Date:  2002-10       Impact factor: 7.196

Review 10.  A note on competing risks in survival data analysis.

Authors:  J M Satagopan; L Ben-Porat; M Berwick; M Robson; D Kutler; A D Auerbach
Journal:  Br J Cancer       Date:  2004-10-04       Impact factor: 7.640

View more
  434 in total

1.  Inference for mutually exclusive competing events through a mixture of generalized gamma distributions.

Authors:  William Checkley; Roy G Brower; Alvaro Muñoz
Journal:  Epidemiology       Date:  2010-07       Impact factor: 4.822

2.  Mortality and Recovery Associated with Kidney Failure due to Acute Kidney Injury.

Authors:  Silvi Shah; Anthony C Leonard; Kathleen Harrison; Karthikeyan Meganathan; Annette L Christianson; Charuhas V Thakar
Journal:  Clin J Am Soc Nephrol       Date:  2020-06-17       Impact factor: 8.237

3.  Uptake and positive predictive value of fecal occult blood tests: A randomized controlled trial.

Authors:  Jessica Chubak; Andy Bogart; Sharon Fuller; Sharon S Laing; Beverly B Green
Journal:  Prev Med       Date:  2013-09-09       Impact factor: 4.018

4.  Resting heart rate and the risk of death and cardiovascular complications in patients with type 2 diabetes mellitus.

Authors:  G S Hillis; M Woodward; A Rodgers; C K Chow; Q Li; S Zoungas; A Patel; R Webster; G D Batty; T Ninomiya; G Mancia; N R Poulter; J Chalmers
Journal:  Diabetologia       Date:  2012-05       Impact factor: 10.122

5.  Midlife Alcohol Consumption and the Risk of Stroke in the Atherosclerosis Risk in Communities Study.

Authors:  Sara B Jones; Laura Loehr; Christy L Avery; Rebecca F Gottesman; Lisa Wruck; Eyal Shahar; Wayne D Rosamond
Journal:  Stroke       Date:  2015-09-24       Impact factor: 7.914

6.  Leisure-Time Physical Activity and Cardiovascular Mortality in an Elderly Population in Northern Manhattan: A Prospective Cohort Study.

Authors:  Ying Kuen Cheung; Yeseon P Moon; Erin R Kulick; Ralph L Sacco; Mitchell S V Elkind; Joshua Z Willey
Journal:  J Gen Intern Med       Date:  2016-10-17       Impact factor: 5.128

7.  Team-based versus traditional primary care models and short-term outcomes after hospital discharge.

Authors:  Bruno D Riverin; Patricia Li; Ashley I Naimi; Erin Strumpf
Journal:  CMAJ       Date:  2017-04-24       Impact factor: 8.262

8.  Negative social interactions and risk of mild cognitive impairment in old age.

Authors:  Robert S Wilson; Patricia A Boyle; Bryan D James; Sue E Leurgans; Aron S Buchman; David A Bennett
Journal:  Neuropsychology       Date:  2014-12-15       Impact factor: 3.295

9.  Pneumonia in the Noninstitutionalized Older Population.

Authors:  Lutz P Breitling; Kai-Uwe Saum; Ben Schöttker; Bernd Holleczek; Felix J Herth; Hermann Brenner
Journal:  Dtsch Arztebl Int       Date:  2016-09-16       Impact factor: 5.594

10.  Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccine Among Patients Receiving Maintenance Hemodialysis.

Authors:  Anne M Butler; J Bradley Layton; Vikas R Dharnidharka; John M Sahrmann; Marissa J Seamans; David J Weber; Leah J McGrath
Journal:  Am J Kidney Dis       Date:  2019-08-01       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.